Jpmorgan Chase & Co »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $37k 38k 0.98
2025-03-31 $30k 38k 0.79
2024-12-31 $30k 38k 0.79
2024-09-30 $25k 38k 0.65
2024-06-30 $25k 38k 0.65
2024-03-31 $20k 38k 0.53
2023-12-31 $19k 38k 0.51
2023-09-30 $26k 38k 0.68
2023-06-30 $26k 38k 0.68
2023-03-31 $29k 38k 0.76
2022-06-30 $655k 900k 0.73
2022-03-31 $2.9M 3.5M 0.82
2021-12-31 $4.3M 5.3M 0.81
2021-03-31 $3.3M 3.0M 1.11
2020-12-31 $3.9M 3.0M 1.30
2020-09-30 $6.9M 5.5M 1.27
2019-12-31 $2.7M 1.8M 1.46

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Affinity Asset Advisors
Opaleye Management
Exome Asset Management
BLB^B Advisors
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1